ROSIGLITAZONE DERIVATIVES AS ANTIDIABETIC AGENTS

摘要

The present invention relates to rosiglitazone derivatives of Formula VI and their pharmaceutically acceptable salts. The invention concerns methods for the preparation of such derivatives, pharmaceutical compositions comprising the same and methods of treatment comprising administration of such compositions. These derivatives are putative metabolites of rosiglitazone.